Entry - #614883 - PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A - OMIM
# 614883

PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A


Other entities represented in this entry:

PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 13, INCLUDED; CG13, INCLUDED
PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP H, INCLUDED; CGH, INCLUDED

Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
2p15 Peroxisome biogenesis disorder 11A (Zellweger) 614883 AR 3 PEX13 601789
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
GROWTH
Other
- Failure to thrive, severe
HEAD & NECK
Head
- Large anterior fontanel
Face
- High forehead
- Large, triangular face
Nose
- Anteverted nostrils
- Depressed nasal bridge
ABDOMEN
Liver
- Hepatic dysfunction, progressive
GENITOURINARY
Kidneys
- Multiple renal cysts
MUSCLE, SOFT TISSUES
- Hypotonia, severe
NEUROLOGIC
Central Nervous System
- Polymicrogyria
- Lissencephaly
- Poor myelination
- Cortical dysfunction seen on EEG
- Seizures
- Recurrent apnea
- Global developmental delay
LABORATORY ABNORMALITIES
- Elevated hexacosanoic acid
- Elevated ratios of tetracosanoic and hexacosanoic acid to docosanoic acid in plasma
- 'Ghost' peroxisomes in fibroblasts seen on immunofluorescence microscopy
- Elevated liver enzymes
MOLECULAR BASIS
- Caused by mutation in the peroxisome biogenesis factor 13 gene (PEX13, 601789.0001)
Peroxisome biogenesis disorder - PS214100 - 27 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.32 Peroxisome biogenesis disorder 6B AR 3 614871 PEX10 602859
1p36.32 Peroxisome biogenesis disorder 6A (Zellweger) AR 3 614870 PEX10 602859
1p36.22 Peroxisome biogenesis disorder 13A (Zellweger) AR 3 614887 PEX14 601791
1q21.1 Peroxisome biogenesis disorder 14B AR 3 614920 PEX11B 603867
1q23.2 Peroxisome biogenesis disorder 12A (Zellweger) AR 3 614886 PEX19 600279
2p15 Peroxisome biogenesis disorder 11B AR 3 614885 PEX13 601789
2p15 Peroxisome biogenesis disorder 11A (Zellweger) AR 3 614883 PEX13 601789
6p21.1 Heimler syndrome 2 AR 3 616617 PEX6 601498
6p21.1 Peroxisome biogenesis disorder 4B AD, AR 3 614863 PEX6 601498
6p21.1 Peroxisome biogenesis disorder 4A (Zellweger) AR 3 614862 PEX6 601498
6q23.3 Peroxisome biogenesis disorder 9B AR 3 614879 PEX7 601757
6q23.3 Rhizomelic chondrodysplasia punctata, type 1 AR 3 215100 PEX7 601757
6q24.2 Peroxisome biogenesis disorder 10A (Zellweger) AR 3 614882 PEX3 603164
6q24.2 ?Peroxisome biogenesis disorder 10B AR 3 617370 PEX3 603164
7q21.2 Peroxisome biogenesis disorder 1B (NALD/IRD) AR 3 601539 PEX1 602136
7q21.2 Peroxisome biogenesis disorder 1A (Zellweger) AR 3 214100 PEX1 602136
7q21.2 Heimler syndrome 1 AR 3 234580 PEX1 602136
8q21.13 Peroxisome biogenesis disorder 5B AR 3 614867 PEX2 170993
8q21.13 Peroxisome biogenesis disorder 5A (Zellweger) AR 3 614866 PEX2 170993
11p11.2 Peroxisome biogenesis disorder 8B AR 3 614877 PEX16 603360
11p11.2 Peroxisome biogenesis disorder 8A (Zellweger) AR 3 614876 PEX16 603360
12p13.31 Peroxisome biogenesis disorder 2B AR 3 202370 PEX5 600414
12p13.31 Peroxisome biogenesis disorder 2A (Zellweger) AR 3 214110 PEX5 600414
17q12 Peroxisome biogenesis disorder 3A (Zellweger) AR 3 614859 PEX12 601758
17q12 Peroxisome biogenesis disorder 3B AR 3 266510 PEX12 601758
22q11.21 Peroxisome biogenesis disorder 7A (Zellweger) AR 3 614872 PEX26 608666
22q11.21 Peroxisome biogenesis disorder 7B AR 3 614873 PEX26 608666

TEXT

A number sign (#) is used with this entry because this form of Zellweger syndrome (PBD11A) is caused by homozygous mutation in the PEX13 gene (601789) on chromosome 2p15.


Description

Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).

For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.

Individuals with PBDs of complementation group 13 (CG13, equivalent to CGH) have mutations in the PEX13 gene. For information on the history of PBD complementation groups, see 214100.


Clinical Features

Al-Dirbashi et al. (2009) studied 2 Saudi patients, children of consanguineous parents, with Zellweger syndrome who were identified in the neonatal intensive care unit (NICU). The first patient was admitted immediately after birth with severe hypotonia. He had large anterior fontanel and high forehead. Magnetic resonance imaging (MRI) of the brain showed polymicrogyria, lissencephaly, and poor myelination. Consistent with the MRI findings, his electroencephalogram (EEG) revealed cortical dysfunction and seizure activity. He died at 6 weeks of age with cardiopulmonary arrest. The second patient was also admitted to NICU shortly after birth because of severe hypotonia and had anteverted nostrils, a depressed nasal bridge, and a large, triangular face. His course was complicated by recurrent apnea, seizures, and elevated liver enzymes. Renal ultrasound revealed the presence of multiple cysts. He remained in the NICU for 4 months before his transfer to the general pediatrics ward where he remained at 6 months of age with severe failure to thrive, progressive hepatic dysfunction, and global developmental delay.


Molecular Genetics

In a patient with a severe Zellweger syndrome phenotype, Shimozawa et al. (1999) found homozygosity for a nonsense mutation in the PEX13 gene (601789.0001).

One patient with Zellweger syndrome studied by Al-Dirbashi et al. (2009) was homozygous for a large deletion encompassing the entire PEX13 gene (601789.0003); the other patient was homozygous for a smaller, out-of-frame deletion (601789.0004).


REFERENCES

  1. Al-Dirbashi, O. Y., Shaheen, R., Al-Sayed, M., Al-Dosari, M., Makhseed, N., Abu Safieh, L., Santa, T., Meyer, B. F., Shimozawa, N., Alkuraya, F. S. Zellweger syndrome caused by PEX13 deficiency: report of two novel mutations. Am. J. Med. Genet. 149A: 1219-1223, 2009. [PubMed: 19449432, related citations] [Full Text]

  2. Shimozawa, N., Suzuki, Y., Zhang, Z., Imamura, A., Toyama, R., Mukai, S., Fujiki, Y., Tsukamoto, T., Osumi, T., Orii, T., Wanders, R. J. A., Kondo, N. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders. Hum. Molec. Genet. 8: 1077-1083, 1999. [PubMed: 10332040, related citations] [Full Text]

  3. Steinberg, S. J., Dodt, G., Raymond, G. V., Braverman, N. E., Moser, A. B., Moser, H. W. Peroxisome biogenesis disorders. Biochim. Biophys. Acta 1763: 1733-1748, 2006. [PubMed: 17055079, related citations] [Full Text]


Creation Date:
Anne M. Stumpf : 10/17/2012
alopez : 02/16/2017
alopez : 02/16/2017
alopez : 10/25/2012
alopez : 10/24/2012

# 614883

PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A


Other entities represented in this entry:

PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 13, INCLUDED; CG13, INCLUDED
PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP H, INCLUDED; CGH, INCLUDED

ORPHA: 79189, 912;   DO: 0080485;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
2p15 Peroxisome biogenesis disorder 11A (Zellweger) 614883 Autosomal recessive 3 PEX13 601789

TEXT

A number sign (#) is used with this entry because this form of Zellweger syndrome (PBD11A) is caused by homozygous mutation in the PEX13 gene (601789) on chromosome 2p15.


Description

Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).

For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.

Individuals with PBDs of complementation group 13 (CG13, equivalent to CGH) have mutations in the PEX13 gene. For information on the history of PBD complementation groups, see 214100.


Clinical Features

Al-Dirbashi et al. (2009) studied 2 Saudi patients, children of consanguineous parents, with Zellweger syndrome who were identified in the neonatal intensive care unit (NICU). The first patient was admitted immediately after birth with severe hypotonia. He had large anterior fontanel and high forehead. Magnetic resonance imaging (MRI) of the brain showed polymicrogyria, lissencephaly, and poor myelination. Consistent with the MRI findings, his electroencephalogram (EEG) revealed cortical dysfunction and seizure activity. He died at 6 weeks of age with cardiopulmonary arrest. The second patient was also admitted to NICU shortly after birth because of severe hypotonia and had anteverted nostrils, a depressed nasal bridge, and a large, triangular face. His course was complicated by recurrent apnea, seizures, and elevated liver enzymes. Renal ultrasound revealed the presence of multiple cysts. He remained in the NICU for 4 months before his transfer to the general pediatrics ward where he remained at 6 months of age with severe failure to thrive, progressive hepatic dysfunction, and global developmental delay.


Molecular Genetics

In a patient with a severe Zellweger syndrome phenotype, Shimozawa et al. (1999) found homozygosity for a nonsense mutation in the PEX13 gene (601789.0001).

One patient with Zellweger syndrome studied by Al-Dirbashi et al. (2009) was homozygous for a large deletion encompassing the entire PEX13 gene (601789.0003); the other patient was homozygous for a smaller, out-of-frame deletion (601789.0004).


REFERENCES

  1. Al-Dirbashi, O. Y., Shaheen, R., Al-Sayed, M., Al-Dosari, M., Makhseed, N., Abu Safieh, L., Santa, T., Meyer, B. F., Shimozawa, N., Alkuraya, F. S. Zellweger syndrome caused by PEX13 deficiency: report of two novel mutations. Am. J. Med. Genet. 149A: 1219-1223, 2009. [PubMed: 19449432] [Full Text: https://doi.org/10.1002/ajmg.a.32874]

  2. Shimozawa, N., Suzuki, Y., Zhang, Z., Imamura, A., Toyama, R., Mukai, S., Fujiki, Y., Tsukamoto, T., Osumi, T., Orii, T., Wanders, R. J. A., Kondo, N. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders. Hum. Molec. Genet. 8: 1077-1083, 1999. [PubMed: 10332040] [Full Text: https://doi.org/10.1093/hmg/8.6.1077]

  3. Steinberg, S. J., Dodt, G., Raymond, G. V., Braverman, N. E., Moser, A. B., Moser, H. W. Peroxisome biogenesis disorders. Biochim. Biophys. Acta 1763: 1733-1748, 2006. [PubMed: 17055079] [Full Text: https://doi.org/10.1016/j.bbamcr.2006.09.010]


Creation Date:
Anne M. Stumpf : 10/17/2012

Edit History:
alopez : 02/16/2017
alopez : 02/16/2017
alopez : 10/25/2012
alopez : 10/24/2012